Newly approved does not always mean new and improved

JAMA. 2008 Apr 2;299(13):1598-600. doi: 10.1001/jama.299.13.1598.
No abstract available

MeSH terms

  • Clinical Trials as Topic
  • Drug Approval*
  • Drug Industry
  • Information Dissemination
  • Marketing
  • Patient Participation
  • Practice Patterns, Physicians'
  • Product Surveillance, Postmarketing*